Regulation of ENaC-mediated sodium reabsorption by peroxisome proliferator-activated receptors

PPAR Research

Volumn , Issue , 2010, Pages

  Staruschenko, Alexander ^a   Pavlov, Tengis S ^a   Imig, John D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; 2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; AMILORIDE; ANTILIPEMIC AGENT; ARACHIDONIC ACID; CLOFIBRATE; EPITHELIAL SODIUM CHANNEL; FARGLITAZAR; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

DRUG WITHDRAWAL; EDEMA; FLUID RETENTION; HEART FAILURE; HUMAN; HYPERTENSION; LIVER TOXICITY; LUNG EDEMA; NATRIURESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SODIUM ABSORPTION; SODIUM TRANSPORT; UPREGULATION;

EID: 77954592777     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/703735     Document Type: Review

References (76)

1. Yki-Jrvinen H., Thiazolidinediones The New England Journal of Medicine 2004 351 11 1106 1158
2. Shearer B. G., Billin A. N., The next generation of PPAR drugs: do we have the tools to find them? Biochimica et Biophysica Acta 2007 1771 8 1082 1093
3. Tontonoz P., Spiegelman B. M., Fat and beyond: the diverse biology of PPAR Annual Review of Biochemistry 2008 77 289 312
4. Kliewer S. A., Xu H. E., Lambert M. H., Willson T. M., Peroxisome proliferator-activated receptors: from genes to physiology Recent Progress in Hormone Research 2001 56 1 239 263
5. Chinetti G., Fruchart J.-C., Staels B., Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflammation Research 2000 49 10 497 505
6. Sato K., Sugawara A., Kudo M., Uruno A., Ito S., Takeuchi K., Expression of peroxisome proliferator-activated receptor isoform proteins in the rat kidney Hypertension Research 2004 27 6 417 425
7. Braissant O., Foufelle F., Scotto C., Daua M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-,-, and- in the adult rat Endocrinology 1996 137 1 354 366
8. Guan Y., Zhang Y., Davis L., Breyer M. D., Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans American Journal of Physiology 1997 273 6 F1013 F1022
9. Yang T., Michele D. E., Park J., Smart A. M., Lin Z., Brosius F. C. III, Schnermann J. B., Briggs J. P., Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney American Journal of Physiology 1999 277 6 F966 F973
10. Robinson E., Grieve D. J., Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease Pharmacology Therapeutics 2009 122 3 246 263
11. Newaz M., Blanton A., Fidelis P., Oyekan A., NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR) -mediated cardiovascular effects Mutation Research 2005 579 1-2 163 171
12. Guellich A., Damy T., Lecarpentier Y., Conti M., Claes V., Samuel J.-L., Quillard J., Hbert J.-L., Pineau T., Coirault C., Role of oxidative stress in cardiac dysfunction of PPAR -/- mice American Journal of Physiology 2007 293 1 H93 H102
13. Loichot C., Jesel L., Tesse A., Tabernero A., Schoonjans K., Roul G., Carpusca I., Auwerx J., Andriantsitohaina R., Deletion of peroxisome proliferator-activated receptor- induces an alteration of cardiac functions American Journal of Physiology 2006 291 1 H161 H166
14. Obih P., Oyekan A., Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPAR null mice Blood Pressure 2008 17 1 55 63
15. Alonso-Galicia M., Frohlich B., Roman R. J., Induction of P4504A activity improves pressure-natriuresis in Dahl S rats Hypertension 1998 31 1 232 236
16. Newaz M. A., Ranganna K., Oyekan A. O., Relationship between PPAR activation and NO on proximal tubular Na+ transport in the rat BMC Pharmacology 2004 4, article 1
17. Horion E. S., Whitehouse F., Ghazzi M. N., Venable T. C., Whitcomb R. W., Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group Diabetes Care 1998 21 9 1462 1469
18. Mudaliar S., Chang A. R., Henry R. R., Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications Endocrine Practice 2003 9 5 406 416
19. Yang T., Soodvilai S., Renal and vascular mechanisms of thiazolidinedione-induced fluid retention PPAR Research 2008
20. Efrati S., Berman S., Ilgiyeav E., Averbukh Z., Weissgarten J., PPAR- activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats Nephron 2007 106 4 e107 e112
21. Song J., Liu H., Ressom H. W., Tiwari S., Ecelbarger C. M., Chronic rosiglitazone therapy normalizes expression of ACE1, SCD1 and other genes in the kidney of obese zucker rats as determined by microarray analysis Experimental and Clinical Endocrinology and Diabetes 2008 116 6 315 325
22. Yousefipour Z., Hercule H., Truong L., Oyekan A., Newaz M. A., Ciglitazone, a peroxisome proliferator-activated receptor inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure Journal of Pharmacology and Experimental Therapeutics 2007 322 2 461 468
23. Diep Q. N., Mabrouk M. E., Cohn J. S., Endemann D., Amiri F., Virdis A., Neves M. F., Schiffrin E. L., Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor- Circulation 2002 105 19 2296 2302
24. Sugawara A., Takeuchi K., Uruno A., Ikeda Y., Arima S., Kudo M., Sato K., Taniyama Y., Ito S., Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor- in vascular smooth muscle cells Endocrinology 2001 142 7 3125 3134
25. Todorov V. T., Desch M., Schmitt-Nilson N., Todorova A., Kurtz A., Peroxisome proliferator-activated receptor- is involved in the control of renin gene expression Hypertension 2007 50 5 939 944
26. Desch M., Schreiber A., Schweda F., Madsen K., Friis U. G., Weatherford E. T., Sigmund C. D., Sequeira Lopez M. L., Gomez R. A., Todorov V. T., Increased renin production in mice with deletion of peroxisome proliferator-activated receptor- in juxtaglomerular cells Hypertension 2010 55 3 660 666
27. Guan Y., Hao C., Cha D. R., Rao R., Lu W., Kohan D. E., Magnuson M. A., Redha R., Zhang Y., Breyer M. D., Thiazolidinediones expand body fluid volume through PPAR stimulation of ENaC-mediated renal salt absorption Nature Medicine 2005 11 8 861 866
28. Zhang H., Zhang A., Kohan D. E., Nelson R. D., Gonzalez F. J., Yang T., Collecting duct-specific deletion of peroxisome proliferator-activated receptor blocks thiazolidinedione-induced fluid retention Proceedings of the National Academy of Sciences of the United States of America 2005 102 26 9406 9411
29. Ishizuka T., Ito O., Tan L., Ogawa S., Kohzuki M., Omata K., Takeuchi K., Ito S., Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney Hypertension Research 2003 26 11 929 936
30. Yoshioka K., Wakino S., Homma K., Kanda T., Tatematsu S., Hasegawa K., Sugano N., Ito O., Omata K., Saruta T., Hayashi K., Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR- ligands in ovariectomized obese rats Obesity 2008 16 5 965 971
31. Nakagawa K., Holla V. R., Wei Y., Wang W.-H., Gatica A., Wei S., Mei S., Miller C. M., Dae R. C., Price E. Jr., Zent R., Pozzi A., Breyer M. D., Guan Y., Falck J. R., Waterman M. R., Capdevila J. H., Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel Journal of Clinical Investigation 2006 116 6 1696 1702
32. Capdevila J. H., Falck J. R., Imig J. D., Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension Kidney International 2007 72 6 683 689
33. Dobrian A. D., Schriver S. D., Khraibi A. A., Prewitt R. L., Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity Hypertension 2004 43 1 48 56
34. Bishop-Bailey D., Warner T. D., PPAR ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor- antagonist The FASEBJ Journal 2003 17 13 1925 1927
35. Roman R. J., P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiological Reviews 2002 82 1 131 185
36. Ito O., Alonso-Galicia M., Hopp K. A., Roman R. J., Localization of cytochrome P-450 4A isoforms along the rat nephron American Journal of Physiology 1998 274 2, part 2 F395 F404
37. Ma J., Qu W., Scarborough P. E., Tomer K. B., Moomaw C. R., Maronpot R., Davis L. S., Breyer M. D., Zeldin D. C., Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney The Journal of Biological Chemistry 1999 274 25 17777 17788
38. Sun P., Lin D.-H., Wang T., Babilonia E., Wang Z., Jin Y., Kemp R., Nasjletti A., Wang W.-H., Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC American Journal of Physiology 2006 291 6 F1192 F1200
39. Sun P., Liu W., Lin D.-H., Yue P., Kemp R., Satlin L. M., Wang W.-H., Epoxyeicosatrienoic acid activates BK channels in the cortical collecting duct Journal of the American Society of Nephrology 2009 20 3 513 523
40. Wei Y., Lin D.-H., Kemp R., Yaddanapudi G. S. S., Nasjletti A., Falck J. R., Wang W.-H., Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways Journal of General Physiology 2004 124 6 719 727
41. Wei Y., Sun P., Wang Z., Yang B., Carroll M. A., Wang W.-H., Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid American Journal of Physiology 2006 290 5 F1163 F1168
42. Wang Z., Wei Y., Falck J. R., Atcha K. R., Wang W.-H., Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways American Journal of Physiology 2008 294 6 F1441 F1447
43. Gu R., Wei Y., Jiang H., Balazy M., Wang W., Role of 20-HETE in mediating the effect of dietary K intake on the apical K channels in the mTAL American Journal of Physiology 2001 280 2 F223 F230
44. Wang W.-H., Lu M., Hebert S. C., Cytochrome P-450 metabolites mediate extracellular Ca2+ -induced inhibition of apical K+ channels in the TAL American Journal of Physiology 1996 271 1 C103 C111
45. Gu R.-M., Wang W.-H., Arachidonic acid inhibits K channels in basolateral membrane of the thick ascending limb American Journal of Physiology 2002 283 3 F407 F414
46. Gu R.-M., Yang L., Zhang Y., Wang L., Kong S., Zhang C., Zhai Y., Wang M., Wu P., Liu L., Gu F., Zhang J., Wang W.-H., CYP-omega-hydroxylation- dependent metabolites of arachidonic acid inhibit the basolateral 10 pS chloride channel in the rat thick ascending limb Kidney International 2009 76 8 849 856
47. Alvarez de la Rosa D. G., Canessa C. M., Fyfe G. K., Zhang P., Structure and regulation of amiloride-sensitive sodium channels Annual Review of Physiology 2000 62 573 594
48. Garty H., Palmer L. G., Epithelial sodium channels: function, structure and regulation Physiological Reviews 1997 77 2 359 396
49. Schild L., The epithelial sodium channel: from molecule to disease Reviews of Physiology, Biochemistry and Pharmacology 2004 151 93 107
50. Bhalla V., Hallows K. R., Mechanisms of ENaC regulation and clinical implications Journal of the American Society of Nephrology 2008 19 10 1845 1854
51. Song J., Knepper M. A., Hu X., Verbalis J. G., Ecelbarger C. A., Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats Journal of Pharmacology and Experimental Therapeutics 2004 308 2 426 433
52. Chen L., Yang B., McNulty J. A., Clifton L. G., Binz J. G., Grimes A. M., Strum J. C., Harrington W. W., Chen Z., Balon T. W., Stimpson S. A., Brown K. K., GI262570, a peroxisome proliferator-activated receptor agonist, changes electrolytes and water reabsorption from the distal nephron in rats Journal of Pharmacology and Experimental Therapeutics 2005 312 2 718 725
53. Pavlov T. S., Levchenko V., Karpushev A. V., Vandewalle A., Staruschenko A., Peroxisome proliferator-activated receptor antagonists decrease Na+ transport via the epithelial Na+ channel Molecular Pharmacology 2009 76 6 1333 1340
54. Artunc F., Sandulache D., Nasir O., Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPAR agonist pioglitazone Pflugers Archiv European Journal of Physiology 2008 456 2 425 436
55. Chen S.-Y., Bhargava A., Mastroberardino L., Meijer O. C., Wang J., Buse P., Firestone G. L., Verrey F., Pearce D., Epithelial sodium channel regulated by aldosterone-induced protein sgk Proceedings of the National Academy of Sciences of the United States of America 1999 96 5 2514 2519
56. Hong G., Lockhart A., Davis B., PPAR activation enhances cell surface ENaC via up-regulation of SGK1 in human collecting duct cells The FASEBJ Journal 2003 17 13 1966 1968
57. Nofziger C., Chen L., Shane M. A., Smith C. D., Brown K. K., Blazer-Yost B. L., PPAR agonists do not directly enhance basal or insulin-stimulated Na+ transport via the epithelial Na+ channel Pflugers Archiv European Journal of Physiology 2005 451 3 445 453
58. Fajas L., Auboeuf D., Rasp E., Schoonjans K., Lefebvre A.-M., Saladin R., Najib J., Laville M., Fruchart J.-C., Deeb S., Vidal-Puig A., Flier J., Briggs M. R., Staels B., Vidal H., Auwerx J., The organization, promoter analysis, and expression of the human PPAR gene The Journal of Biological Chemistry 1997 272 30 18779 18789
59. Vallon V., Lang F., New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure Current Opinion in Nephrology and Hypertension 2005 14 1 59 66
60. Wilson S. M., Mansley M. K., Getty J., Husband E. M., Inglis S. K., Hansen M., Effects of peroxisome proliferator-activated receptor g agonists on Na+ transport and activity of the kinase sgk1 in epithelial cells from lung and kidney British Journal of Pharmacology 2010 159 3 678 688
61. Vallon V., Hummler E., Rieg T., Pochynyuk O., Bugaj V., Schroth J., Dechenes G., Rossier B., Cunard R., Stockand J., Thiazolidinedione-induced fluid retention is independent of collecting duct ENaC activity Journal of the American Society of Nephrology 2009 20 4 721 729
62. Khan O., Riazi S., Hu X., Song J., Wade J. B., Ecelbarger C. A., Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone American Journal of Physiology 2005 289 2 F442 F450
63. Rubera I., Loffing J., Palmer L. G., Frindt G., Fowler-Jaeger N., Saurer D., Carroll T., McMahon A., Hummler E., Rossier B. C., Collecting duct-specific gene inactivation of ENaC in the mouse kidney does not impair sodium and potassium balance Journal of Clinical Investigation 2003 112 4 554 565
64. Karpushev A. V., Levchenko V., Pavlov T. S., Lam V., Vinnakota K. C., Vandewalle A., Wakatsuki T., Staruschenko A., Regulation of ENaC expression at the cell surface by Rab11 Biochemical and Biophysical Research Communications 2008 377 2 521 525
65. Staruschenko A., Patel P., Tong Q., Medina J. L., Stockand J. D., Ras activates the epithelial Na+ channel through phosphoinositide 3-OH kinase signaling The Journal of Biological Chemistry 2004 279 36 37771 37778
66. Staruschenko A., Booth R. E., Pochynyuk O., Stockand J. D., Tong Q., Functional reconstitution of the human epithelial Na+ channel in a mammalian expression system Methods in Molecular Biology 2006 337 3 13
67. Soodvilai S., Aoyagi K., Yang T., PPARgamma stimulates paracellular transport and inhibits ENaC in primary inner medullary collecting duct cells Journal of the American Society of Nephrology 2009 20 123A
68. Panchapakesan U., Pollock C., Saad S., Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptake Nephrology 2009 14 3 298 301
69. Saad S., Agapiou D. J., Chen X.-M., Stevens V., Pollock C. A., The role of Sgk-1 in the upregulation of transport proteins by PPAR- agonists in human proximal tubule cells Nephrology Dialysis Transplantation 2009 24 4 1130 1141
70. Ollero M., Junaidi O., Zaman M. M., Decreased expression of peroxisome proliferator activated receptor in CFTR-/- mice Journal of Cellular Physiology 2004 200 2 235 244
71. Nofziger C., Brown K. K., Smith C. D., PPAR agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line American Journal of Physiology 2009 297 1 F55 F62
72. Nofziger C., Blazer-Yost B. L., PPAR agonists, modulation of ion transporters, and fluid retention Journal of the American Society of Nephrology 2009 20 12 2481 2483
73. Blazer-Yost B. L., PPAR agonists: blood pressure and edema PPAR Research 2010
74. Bajwa P. J., Lee J. W., Straus D. S., Lytle C., Activation of PPAR by rosiglitazone attenuates intestinal Cl- secretion American Journal of Physiology 2009 297 1 G82 G89
75. Nichols D. P., Konstan M. W., Chmiel J. F., Anti-inflammatory therapies for cystic fibrosis-related lung disease Clinical Reviews in Allergy and Immunology 2008 35 3 135 153
76. Harmon G. S., Dumlao D. S., Ng D. T., Pharmacological correction of a defect in PPAR- signaling ameliorates disease severity in Cftr-deficient mice Nature Medicine 2010 16 3 313 318